Dongkook Pharmaceutical Co Stock Price To Book
| 086450 Stock | KRW 16,610 30.00 0.18% |
DongKook Pharmaceutical Co fundamentals help investors to digest information that contributes to DongKook Pharmaceutical's financial success or failures. It also enables traders to predict the movement of DongKook Stock. The fundamental analysis module provides a way to measure DongKook Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DongKook Pharmaceutical stock.
DongKook |
DongKook Pharmaceutical Co Company Price To Book Analysis
DongKook Pharmaceutical's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, DongKook Pharmaceutical Co has a Price To Book of 0.0 times. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
DongKook Fundamentals
| Return On Equity | 12.72 | |||
| Return On Asset | 0.0608 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.08 T | |||
| Shares Outstanding | 8.79 M | |||
| Shares Owned By Insiders | 46.60 % | |||
| Shares Owned By Institutions | 17.00 % | |||
| Price To Earning | 19.52 X | |||
| Price To Sales | 0.24 X | |||
| Revenue | 594.19 B | |||
| Gross Profit | 337.12 B | |||
| EBITDA | 83.48 B | |||
| Net Income | 52.92 B | |||
| Cash And Equivalents | 85.44 B | |||
| Total Debt | 13.69 B | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 2.61 X | |||
| Book Value Per Share | 23,358 X | |||
| Cash Flow From Operations | 44.65 B | |||
| Target Price | 22667.0 | |||
| Number Of Employees | 1.06 K | |||
| Beta | 1.09 | |||
| Market Capitalization | 145.91 B | |||
| Total Asset | 750.08 B | |||
| Retained Earnings | 172.22 B | |||
| Working Capital | 139.53 B | |||
| Current Asset | 203.59 B | |||
| Current Liabilities | 64.06 B | |||
| Z Score | 6.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 750.08 B |
About DongKook Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DongKook Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DongKook Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DongKook Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in DongKook Stock
DongKook Pharmaceutical financial ratios help investors to determine whether DongKook Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DongKook with respect to the benefits of owning DongKook Pharmaceutical security.